Mers-CoV 'On Course' According to the Published Genomic Replikin Count Predictions of 2012 and 2013 Comparison with the Replikins Counts and Course of the SARS Outbreak of 2003 and the H1N1 Pandemic of 2009

Completed in 4 days, First Batch of 20,000 doses of Freeze-Dried Solid Phase Synthetic Anti-Mers-CoV Vaccine Is Ready for Testing Today

LONDON, April 30, 2014 /PRNewswire/ -- Bioradar UK Ltd. and Replikins Ltd. announced today that the clinical course of the current Mers-CoV outbreak in southeast Asia is 'on course' according to the genomic Replikin Count predictions published on October 10, 2012  and on October 21, 2013.


Samuel Bogoch, MD, PhD
(646) 320-5910

Read more news from Replikins.

SOURCE Replikins

More by this Source

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.


PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.